David M. Davis Visiting Professor 2022

Philadelphia, PA US
June 17, 2022

IMPORTANT BROWSER INFORMATION

This site will not work on Internet Explorer 8. Please use:

Google Chrome      Mozilla FIREFOX   Safari     Opera

Overview

The David M Davis Visiting Professorship is a year-end program that invites a distinguished Urologist to provide a series of lectures on their topic of expertise. There is also an interactive case presentation activity between the residents and the Visiting Professor which reinforces the topics discussed in the lecture components. This program is targeted at the faculty, resident, advanced practice provider staff and students in the Department of Urology.

This year Dr. Gopal Badlani, Professor and Vice-Chair of the Wake Forest Department of Urology in South Carolina will be highlighting the event. He is a world expert in urinary incontinence and female pelvic reconstructive medicine and surgery.  He will focus his lectures on the work-up of patients with lower urinary tract symptoms (with a focus on urinary incontinence), the most common reason patients present for evaluation at a urologist.
 

The diagnosis and management of these symptoms are complex, and urologists need to be well versed in the appropriate work-up and treatment approaches. These are important to improve patient outcomes, satisfaction and quality of life while providing health care which also reduces costs. 

Successful Completion

To successfully complete this activity, the required evaluation must be completed no later than Monday, August 1, 2022. Thereafter, the evaluation will no longer be available and credits will not be issued. No refunds will be offered for failure to complete the required evaluation by the stated deadline.

Registration/Information

To register or for more information, contact Barbara Devine.

Target Audience

This course is designed for physicians and nurses.

Learning Objectives

Following completion of this activity, learners will be able to:

  • Identify common and uncommon symptoms of lower urinary tract symptoms, primarily focusing on urinary incontinence.
  • Select the appropriate invasive and non-invasive work-up strategy for a patient presenting with urinary incontinence.
  • List the currently available and recommended treatment options for patients with urinary incontinence.
  • Classify the appropriate treatment approach in a patient who presents complaining of urinary incontinence.
  • Summarize emerging novel treatment strategies for urinary incontinence.
Additional information
Jefferson Content Development By: 
Jefferson College of Pharmacy
Content Areas: 
Population Health
Course Format: 
Live Conference
Course summary
Available credit: 
  • 4.25 AMA PRA Category 1 Credit
  • 4.25 Attendance
  • 4.25 CNE
  • 3.25 CNE Pharmacotherapy
  • 1.50 Patient Safety
Course opens: 
04/27/2022
Course expires: 
08/01/2022
Event starts: 
06/17/2022 - 7:15am EDT
Event ends: 
06/17/2022 - 2:15pm EDT
Cost:
$0.00

Commercial/In-Kind Support

 This educational activity has no commercial or in-kind support.

Agenda

Agenda subject to change.


TJU Hamilton Building
1001 Locust Street
5th Floor Lobby & Room 505
Philadelphia, PA 19107
United States

In-Person

5th Floor Hamilton Building (5th Floor Lobby & Room 505)
1001 Locust Street, Philadelphia, PA 19107

Online

This activity will be offered through Zoom. The zoom meeting link, meeting ID, and password will be emailed to registered participants.

Visiting Professor

Dr. Gopal Badlani is a professor and vice-chair, Urology, at Wake Forest Baptist Medical Center in Winston-Salem, N.C. He is also the co-director of their Female Pelvic Medicine and Reconstructive Surgery Fellowship.  He is the editor of several textbooks and has authored more than 200 publications and book chapters.

Dr. Badlani is recognized as a world expert in the field of urinary incontinence and has been invited nationally and internationally as a visiting professor. He served a four-year term as Secretary General of the AUA and was a member of the Advisory Council of the NIDDK. His many awards and honors attest to his contributions to the field of Urology.


 

Relevant Financial Relationships

Thomas Jefferson University Office of Continuing Professional Development (OCPD) endorses the ACCME Standards for Commercial Support: Standards to Ensure Independence in CME Activities and the policies that supplement the Standards. All planners, faculty, authors, presenters, and content reviewers are required to disclose any financial relationships with ACCME defined ineligible entities within the past 24 months. Any conflict of interests have been mitigated prior to the educational activity.

Such disclosures will be available prior to the start of the activity. ​OCPD Conflict of Interest resolution process may result in changes to the program agenda.

Planning Committee

The following planners have no financial relationships to declare.
Patrick T. Gomella, MD, MPH-Activity Director
Alana M. Murphy, MD
Whitney R. Smith, MD
The following planner has financial relationships to declare.
Anne Lizardi-Calvaresi, DNP, CRNP, RNFA
Consultant: Cysview, Decipher, Janssen, Tolmar

Faculty

Mauro Dispagna, MD
Aseem Malhotra, MD
Anthony Tokarski, MD

The following faculty have no financial relationships to disclose.
Brian Calio, MD
Patrick T. Gomella, MD, MPH
Edward Kloniecke, MD
Victor Kucherov, MD
JoonYau Leong, MD
Radhika Ragam, MD
Benjamin Rudnick, MD
Andrew Salib, MD
Alex Uhr, MD
Courtney Capella, MD
Halle Foss, MD
Maria D’Amico, MD

The following faculty have financial relationships to disclose.
Gopal H. Badlani, MD
Advisor: Olympus, Teleflex
Anne Lizardi-Calvaresi, DNP, CRNP, RNFA
Consultant: Cysview, Decipher, Janssen, Tolm

Off‐label/Investigational Use

All faculty/presenters/authors at Thomas Jefferson University sponsored events are required to disclose whether or not their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved. Product(s) is/are not included in the labeling approved by the U.S. FDA for the treatment of disease(s).

Content Disclaimer

The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices or Thomas Jefferson University.

It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice.
 

 

Accreditation

https://jointaccreditation.org/sites/default/files/JointlyAccreditedProviderTM_0.pngIn support of improving patient care, Thomas Jefferson University is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Credit Designation

Physicians: This educational activity is designated for a maximum of 4.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: This activity awards 4.25 nursing contact hours.

Other Healthcare Professionals: This educational activity is designated for 4.25 AMA PRA Category 1 Credits™. Participants should claim only the credit commensurate with the extent of their participation in the activity.

OTHER CREDIT TYPES

PA Patient Safety and Risk credit
This educational activity offers 1.50 credits. The following sessions qualifies: Review Diagnosis and Management of Urology Cases Part 1 and 2

Nursing Pharmacology credit
This educational activity offers 3.25 nursing pharmacology credit. The following session qualifies:

  • Symptom Based Diagnosis of LUTS
  • Review Diagnosis and Management of Urology Cases Part 1
  • Regenerative Pharmacology: Experimental Models
  • Review Diagnosis and Management of Urology Cases Part 2

Available Credit

  • 4.25 AMA PRA Category 1 Credit
  • 4.25 Attendance
  • 4.25 CNE
  • 3.25 CNE Pharmacotherapy
  • 1.50 Patient Safety

Price

Cost:
$0.00
Please login or register to take this course.

Registration/Information

To register or for more information, contact Barbara Devine.

RECORDING AND PHOTOGRAPHY STRICTLY PROHIBITED

Unauthorized recording or photography at a Jefferson-sponsored event is strictly prohibited. Individuals found violating this policy will be removed from the online activity or asked to leave from the live activity. No credits or refund will be issued.

JEFFERSON RELEASE POLICY

Jefferson may record/livestream/photograph this activity. These images/recordings, along with your name, may be used in Jefferson publications or on the Jefferson website. If you verbally submit any questions for Q&A sessions, you are agreeing to be recorded and to have that recording available in enduring materials. Once photographed, filmed, recorded, or videotaped, you waive any right of inspection or approval to which such images/recordings may be put and Jefferson has the right to use, publish, reproduce, modify, adapt and distribute at any time in any manner or medium.

You understand that it is your right to withhold consent to this Jefferson policy or to withdraw your previous consent at any time. You further understand that, without your consent, it is not possible to process your course registration request.

JEFFERSON HIPAA POLICY

You understand that, as an attendee of this conference hosted by Thomas Jefferson University, Jefferson University Physicians and Thomas Jefferson University Hospitals, Inc. (collectively “Jefferson”), you may gain access to certain proprietary information (“Confidential Information”), including Protected Health Information (“PHI”).

You agree to maintain the confidentiality of all Confidential Information, including PHI, obtained from any source. You agree that you will take all necessary steps to protect such Confidential Information and shall not directly or indirectly disclose or use it in any manner or for any reason, other than as necessary to complete the activity.

In furtherance of the above, you agree not to take photographs, record in any manner or otherwise reproduce any such Confidential Information. You understand that any unauthorized use or disclosure of Confidential Information by the undersigned may result in possible legal action against you by Jefferson whose confidentiality is breached.